A Randomized Trial Investigating the Pharmacokinetics, Pharmacodynamics, and Safety of Subcutaneous Semaglutide Once-Weekly in Healthy Male Japanese and Caucasian Subjects

INTRODUCTION: Semaglutide is a glucagon-like peptide-1 analogue for once-weekly subcutaneous treatment of type 2 diabetes. This trial compared the pharmacokinetics, pharmacodynamics, and safety of semaglutide in Japanese and Caucasian subjects. METHODS: In this single-center, double-blind, parallel-...

Descripción completa

Detalles Bibliográficos
Autores principales: Ikushima, Ippei, Jensen, Lene, Flint, Anne, Nishida, Tomoyuki, Zacho, Jeppe, Irie, Shin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5910468/
https://www.ncbi.nlm.nih.gov/pubmed/29536338
http://dx.doi.org/10.1007/s12325-018-0677-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5910468/
https://www.ncbi.nlm.nih.gov/pubmed/29536338
http://dx.doi.org/10.1007/s12325-018-0677-1

Ejemplares similares